Skip to main content
SpringerLink
Log in

Thrombotic microangiopathy and intravenous immunoglobulin therapy

  • Letter to the Editors
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ito S, Okuyama K, Nakamura T, Tetanishi J, Saito K, Matsumoto M, Fujimura Y, Aihara Y, Yokota S (2007) Intravenous gamma globulin for thrombotic microangiopathy of unknown etiology. Pediatr Nephrol 22:301–305

    Article  Google Scholar 

  2. Tsai HM (2006) The molecular biology of thrombotic microangiopathy. Kidney Int 70:16–23

    Article  CAS  Google Scholar 

  3. Fremeaux-Bacchi V, Kemp EJ, Goodship JA, Dragon-Durey MA, Strain L, Loirat C, Deng HW, Goodship THJ (2005) The development of atypical haemolytic-uremic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts. J Med Genet 42:852–856

    Article  CAS  Google Scholar 

  4. Zipfel PF, Skerka C (2006) Complement dysfunction in hemolytic uremic syndrome. Curr Opin Rheumatol 18:548–555

    Article  CAS  Google Scholar 

  5. Dragon-Durey MA, Loirat C, Cloarec S, Macher MA, Blouin J, Nivet H, Weiss L, Fridman WH, Frémeaux-Bacchi V (2005) Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 16:555–563

    Article  CAS  Google Scholar 

  6. Centurioni R, Bobbio-Pallavicini E, Porta C, Rodeghiero F, Gugliotta L, Billio A, Tacconi F, Ascari E, the Italian Cooperative Group for TTP (1995) Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Haematologica 80:325–331

    CAS  PubMed  Google Scholar 

  7. Dervenoulas J, Tsirigotis P, Bollas G, Koumarianou AA, Pappa V, Mantzios G, Xiros N, Economopoulos T, Papageorgiou E, Pappa M, Raptis SA (2001) Efficacy of intravenous immunoglobulin in the treatment of thrombotic thrombocytopenic purpura. A study of 44 cases. Acta Haematol 105:204–208

    Article  CAS  Google Scholar 

  8. Ephrem A, Misra N, Hassan G, Dasgupta S, Delignat S, Duong Van Huyen JP, Chamat S, Prost F, Lacroix-Desmazes S, Kavery SV, Kazatchkine MD (2005) Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin. Clin Exp Med 5:135–140

    Article  CAS  Google Scholar 

  9. Jefferson JA, Suga S, Kim YG, Pippin J, Gordon KL, Johnson RJ, Couser WG (2001) Intravenous immunoglobulin protects against experimental thrombotic microangiopathy. Kidney Int 60:1018–1025

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Niigata City General Hospital, 2-6-1 Shichikuyama, Niigata, 950-8739, Japan

    Toru Watanabe

Authors
  1. Toru Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Toru Watanabe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Watanabe, T. Thrombotic microangiopathy and intravenous immunoglobulin therapy. Pediatr Nephrol 22, 907–908 (2007). https://doi.org/10.1007/s00467-007-0441-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-007-0441-2

Keywords

Search

Navigation